Keyphrases
Cardiac Tissue
50%
Hepatic Tissue
50%
Sirolimus
50%
MTOR Inhibitor
50%
Mammalian Target of Rapamycin (mTOR)
37%
Cellular Respiration
35%
Cellular Bioenergetics
30%
C57BL
29%
Bioenergetic Metabolism
25%
Renal Tissue
25%
Flat Epithelial Atypia
25%
Mammary Hamartoma
25%
Duodenal Biopsy
25%
Core-shell Nanoparticles
25%
In Vitro Assessment
25%
Teratocarcinosarcoma
25%
CTNNB1 mutation
25%
GSK2126458
25%
Intraocular Mass
25%
NOD-like Receptor Protein 3 (NLRP3)
25%
B Signaling Pathway
25%
Respiratory Syncytial Virus
25%
Tacrolimus
25%
Carcinoid Tumor
25%
Pulmonary Carcinoid
25%
Tumor-associated
25%
Cushing's Syndrome
25%
Lung
25%
Juvenile Xanthogranuloma
25%
Mitochondrial Modulator
25%
Osteopetrosis
25%
In Vivo Preclinical Studies
25%
Thymic Involution
25%
Molecular Targeted Therapy
25%
Target of Rapamycin Inhibitor
25%
Mimickers
25%
Thymic Cyst
25%
Secondary Neoplasms
25%
Metachronous
25%
Extremity Soft Tissue Sarcoma
25%
Archival Tissue
25%
Renal Cell Carcinoma Metastasis
25%
Legal Considerations
25%
High-risk HPV
25%
Cervical High-grade Squamous Intraepithelial Lesions
25%
Experimental Pathology
25%
Sleeve Gastrectomy
25%
Sebaceous Lymphadenoma
25%
Giant Cell
25%
Osteoclast-like
25%
School Learning Environment
25%
Tetratricopeptide Repeat Domain 7A (TTC7A)
25%
TTC7A mutation
25%
Hereditary multiple Intestinal Atresia
25%
Competence Building
25%
Murine Liver
25%
Murine Lung
25%
Mammalian Target of Rapamycin Pathway
25%
PTEN Deletion
25%
Copy number Profiling
25%
Lymphoplasmacytic Lymphoma
25%
PI3K Inhibitor
25%
Idelalisib
25%
Uterine Cervix
25%
Waldenström Macroglobulinemia
25%
Metachromatic Leukodystrophy
25%
Gallbladder Polyp
25%
Silver Nanoparticles
25%
Pleuropulmonary Blastoma
25%
Cytological Findings
25%
Stress Cascade
25%
Epithelioid Trophoblastic Tumor
25%
Intestinal Atresia
18%
Metastatic Renal Cell Carcinoma (mRCC)
18%
Liposarcoma
16%
Parotid Mass
16%
Innovation in Medical Education
16%
Tissue Preparation
16%
RSV Infection
16%
Rapamycin
16%
Bone Marrow Transplantation
12%
Second Malignant Neoplasm
12%
Long Follow-up
12%
Activation Status
12%
Cyclosporine
12%
Villous Atrophy
12%
NKX3.1
11%
Student-faculty Interaction
10%
Optimal Learning Environment
10%
Post-infection
10%
Gallbladder Pathology
10%
Respiratory Syncytial Virus Infection
10%
O2 Consumption
9%
Serine-threonine Kinase
8%
Calcineurin
8%
Lymphokines
8%
Serine/threonine Protein Phosphatase
8%
Sensitive Biomarker
8%
Energy Conversion Process
8%
Control Energy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Rapamycin
100%
Colitis
100%
Mouse
93%
Adenosine Triphosphate
58%
Peroxisome Proliferator Activated Receptor
52%
Transcription Factors
50%
Influenzavirus A
50%
Bisabolol
50%
Caspase
48%
Inflammation
47%
Antioxidant
37%
Mitogen Activated Protein Kinase
35%
Mammalian Target of Rapamycin
35%
Biological Marker
34%
Inflammatory Bowel Disease
33%
Disease
33%
Infection
31%
Antiinflammatory Activity
31%
Mammalian Target of Rapamycin Inhibitor
30%
Bagg Albino Mouse
30%
Lung Toxicity
30%
Hyperglycemia
27%
Sesquiterpene
27%
Silicon Dioxide
25%
Virus Infection
25%
Antitumor Activity
25%
Omipalisib
25%
Human Respiratory Syncytial Virus
25%
Antioxidant Capacity
25%
Cineole
25%
Thymoquinone
25%
Myrcene
25%
PPAR Agonist
25%
Nanoparticle
25%
Cannabinoid
25%
N Ethylmaleimide
25%
Caryophyllene
25%
Platinum Derivative
25%
Renal Cell Carcinoma
25%
Idelalisib
25%
Diabetic Cardiomyopathy
25%
Metformin
25%
Nuclear Factor
25%
Alternative Complement Pathway C3 C5 Convertase
25%
Doxorubicin
25%
Cardiotoxicity
25%
Tacrolimus
21%
Ciclosporin
21%
Chronic Disease
18%
Tumor Necrosis Factor
18%
Immunosuppressive Agent
18%
Cisplatin
15%
Thiol
15%
Caspase 3
13%
Acetic Acid Derivative
13%
Adverse Event
12%
Sevoflurane
12%
Human Papillomavirus Type 18
12%
Oxaliplatin
12%
Carboplatin
12%
Buffer
11%
Anti-Inflammatory Drug
10%
Phytochemical
10%
C57BL 6 Mouse
10%
Adenocarcinoma
9%
Protein Serine Threonine Kinase
9%
Nephrotoxicity
9%
Kidney Metastasis
9%
Cannabinoid
9%
Myeloperoxidase
8%
Disease Activity
8%
Immunoglobulin Enhancer Binding Protein
8%
Lipid
8%
Luciferin
8%
Luciferase
8%
High Performance Liquid Chromatography
8%
Incubation Time
8%
Crohn's Disease
7%
Ulcerative Colitis
7%
Cytokine
7%
CXCL1 Chemokine
7%
Dextran Sulfate
7%
Calcineurin
7%
Serine
7%
Threonine
7%
Phosphatase
7%
Lymphokine
7%
Pneumonia
6%
Kidney Tubule Necrosis
6%
Malignant Neoplasm
6%
Polyphenol
6%
Cardiovascular Disease
6%
Biochemical Marker
6%
Wistar Rat
6%
Cardiovascular System Cancer
6%
Epileptic Absence
6%
Receptor Protein
6%
Combination Therapy
5%
Pharmacotherapy
5%
Chemokine
5%
Medicine and Dentistry
Rapamycin
75%
Cell Respiration
50%
Mechanistic Target of Rapamycin
35%
Mammalian Target of Rapamycin Inhibitor
28%
Drug Resistance
25%
Morphology
25%
Hamartoma
25%
Protein Glutamine Gamma Glutamyltransferase
25%
Duodenum Biopsy
25%
Molecularly Targeted Therapy
25%
Involution
25%
Omipalisib
25%
Cushing Syndrome
25%
Carcinoid
25%
Hyperglycemia
25%
Influenza A Virus
25%
Albers Schoenberg Disease
25%
Thymus Cyst
25%
Juvenile Xanthogranuloma
25%
Clear Cell Renal Cell Carcinoma
25%
Clinical Pathology
25%
Experimental Pathology
25%
Sleeve Gastrectomy
25%
Osteoclast
25%
Lymph Node Hyperplasia
25%
Metachromatic Leukodystrophy
25%
Glycon
25%
Uterine Cervix
25%
Waldenström's Macroglobulinemia
25%
Pleuropulmonary Blastoma
25%
Platinum Derivative
25%
Gestational Trophoblastic Disease
25%
Breast Cancer
25%
Inflammasome
25%
Intestine Atresia
25%
Tacrolimus
21%
Immunosuppressant
14%
Liposarcoma
14%
Bone Marrow Transplantation
12%
Human Papillomavirus Type 18
12%
Cyclosporine
10%
Breast Tumor
10%
Intestine Villus Atrophy
10%
Kidney Metastasis
9%
Cannabinoid
9%
Cytoreductive Surgery
8%
Debulking Surgery
8%
Blastema
8%
Neuroepithelium
8%
ICE (Chemotherapy)
8%
Lobectomy
8%
Bronchus Carcinoid
8%
Corticotropin
8%
Sebaceous Cell
8%
Biological Marker
7%
Leiomyosarcoma
7%
C57BL/6
7%
Phosphatase
7%
Threonine
7%
Serine
7%
Lymphokine
7%
Calcineurin
7%
Protein Serine Threonine Kinase
7%
Benign Breast Tumor
6%
Pulmonary Pathology
6%
Thymocyte
5%
Idelalisib
5%
Neoadjuvant Therapy
5%
Hormone Therapy
5%
Mitochondrial Respiration
5%
Retrospective Study
5%
Antiinfective Agent
5%
Disease Free Survival
5%
Hemosiderin
5%
Epidermal Growth Factor Receptor 2
5%
Sentinel Lymph Node Biopsy
5%
Lumpectomy
5%
Gamma Urogastrone
5%
Osteoclast Differentiation Factor
5%
Progesterone Receptor
5%
Cell Component
5%
Inflammatory Bowel Disease
5%
Intestine Stenosis
5%
Severe Combined Immunodeficiency
5%
Eosinophil
5%
Immunoglobulin Producing Cell
5%
Pandemic
5%
Prospective Study
5%
Cerebroside Sulfatase
5%
Demyelination
5%
Drug Sensitivity
5%
Methylation
5%
Hysterectomy
5%
Lung Malformation
5%
Emphysema
5%
Uterus Bleeding
5%
Congenital Pulmonary Cyst
5%
Predictive Marker
5%
Cancer Cell Line
5%
